KYLENE CAMILLETTI: Open Payments
NPI 1902439235 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 18 payments from 11 companies in 2025. Trend: 2023 $2,251 · 2024 $519 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Boston Scientific Corporation | 1 | $93 |
| BridgeBio Pharma, Inc. | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| AtriCure, Inc. | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: LEQVIO, FARAPULSE, Attruby, Kerendia, OPSUMIT, Wegovy, FARXIGA, SYNERGY ABLATION SYSTEM.
Industry payments across OH — which companies pay providers there.
